Search for: "Monsanto v. Monsanto" Results 501 - 520 of 707
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 May 2007, 10:46 am
A recent decision from the High Court illustrates how it might be overambitious to claim patent rights over a new product when all you have done is show one way of making it.In Generics (UK) Ltd & Ors v H Lundbeck A/S, decided last Friday by Mr Justice Kitchin at the High Court, Lundbeck's patent covering Cipralex (citalopram, right) was partially revoked on application by the claimants under section 72 for being insufficiently disclosed. [read post]
24 Feb 2021, 9:11 am by Miquel Montañá (Clifford Chance)
This logic was followed by the U.S. courts in Monsanto v. [read post]
6 Oct 2010, 4:22 am by Kelly
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated… [read post]
19 Apr 2011, 5:04 pm by Marie Louise
General What to do in the face of a patent cliff: A view from Medium Pharma (IP finance) (IP finance) Study: Patent applications rise on flu genetic resources; questioning WIPO report (IP Watch) WHO group strikes landmark deal on global framework for flu pandemics (IP Watch) (IP Watch) Book explores intersection of policymaking in IP, biodiversity (IP Watch) Australia: Painaway case reveals some painful IP licensing lessons: Painaway Australia v JAKL Group (IP Whiteboard) Australia: Update… [read post]
26 Oct 2011, 2:30 am by Marie Louise
Prometheus Labs (Patently-O) US: Pioneer-DuPont sues Monsanto for infringing “low tech” agricultural biotechnology patents (Holman’s Biotech IP Blog)   Products Arzerra (Ofatumumab) / Rituxan (Rituximab)– US: Claim construction ruling in Arzerra infringement case: Biogen Idec and Genentech v. [read post]
23 Dec 2009, 12:40 am
Sandoz Limited (EPLAW) Fuzeon (Enfuvirtide) - US: If there are no sources of proof in the E D of Texas, expect to transferred: In re Hoffman-La Roche Inc (Filewrapper) Gemzar (Gemcitabine) – US: Eli Lilly appeals from grant of partial summary judgment finding certain claims invalid for double patenting: Sun Pharma v Eli Lilly (PATracer) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against APP Pharmaceuticals following Para IV challenge (Patent Docs)… [read post]